Natera Announces Three New Signatera Publications; Includes Groundbreaking Overall ...

Natera announces 3 peer-reviewed Signatera papers, reaching over 85 publications, including groundbreaking colorectal cancer data from the GALAXY trial and a new study on immune checkpoint inhibitors in triple negative breast cancer.